한글목차

세계의 망막 박리 진단 시장 규모는 2024년 21억 달러로, 2030년까지 연평균 복합 성장률(CAGR) 5.45%로 견조한 성장이 예측되고 있습니다.

세계의 망막 박리 진단 시장은 보다 광범위한 안과 및 안과 의료 분야 중에서도 중요한 부문이며, 주로 망막 박리(망막이 아래의 조직으로부터 벗겨져 떨어지는 시력을 위협하는 상태)의 진단과 조기 발견에 초점을 맞추었습니다. 이 시장에는 망막 박리나 관련 질환을 특정 및 평가하는 전문가가 사용하는 다양안 진단 도구, 기술, 서비스가 포함됩니다.

세계의 망막 박리 진단 시장은 몇 가지 중요한 요인에 의해 꾸준히 성장하고 있습니다. 장비 수요가 증가하고 있으며, 눈 건강에 대한 의식이 높아지고 정기적 인 안과 검진의 중요성이 조기 진단과 조기 치료를 요구하는 개인을 촉진하고 시장 성장에 기여하고 있습니다.

진단기기의 기술적 진보로 망막 박리 진단의 정확성과 효율이 대폭 향상되고 있습니다.

시장 성장 촉진요인

망막 질환의 유병률 증가

주요 시장 과제

비용 제약

주요 시장 동향

원격 의료 및 원격 모니터링

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 망막 박리 진단 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 질환 유형별(열공원성 망막 박리, 삼출성 망막 박리, 장액성 망막 박리, 2차성 망막 박리, 견인성 망막 박리)
  • 진단법별(안저 사진, 안저 검사, 디지털 망막 카메라, 형광 망막 혈관 조영, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 망막 박리 진단 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미: 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 망막 박리 진단 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽: 국가별 분석
  • 독일
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 망막 박리 진단 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 아시아태평양: 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 망막 박리 진단 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 망막 박리 진단 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카: 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 합병과 인수

제13장 세계의 망막 박리 진단 시장 : SWOT 분석

제14장 경쟁 구도

• Canon Medical Systems Corporation
• Carl Zeiss Meditec Inc.
• Revenio Group Corporation(Centervue SpA)
• Eyenuk Inc.
• Essilor International SA
• HealPros LLC
• Millennium Surgical Corp.
• ONL Therapeutics
• Peek Vision Ltd
• Parata Systems(Synergy Medical) LLC

제15장 전략적 제안

제16장 기업 소개와 면책사항

영문목차

Global Retinal Detachment Diagnostic Market was valued at USD 2.10 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 5.45% through 2030. The Global Retinal Detachment Diagnostics Market is a crucial segment within the broader ophthalmology and eye care sector, primarily focusing on the diagnosis and early detection of retinal detachment-a sight-threatening condition where the retina peels away from the underlying tissue. This market encompasses various diagnostic tools, technologies, and services used by healthcare professionals to identify and assess retinal detachment and related disorders.

The Global Retinal Detachment Diagnostics Market has been steadily growing due to several key factors. As the aging population increases worldwide, the prevalence of retinal detachment and other retinal disorders rises, thereby driving the demand for diagnostic services and equipment. Additionally, the growing awareness of eye health and the importance of regular eye check-ups have prompted individuals to seek early diagnosis and treatment, contributing to market growth.

Technological advancements in diagnostic devices have significantly improved the accuracy and efficiency of retinal detachment diagnosis. High-resolution imaging techniques like Optical Coherence Tomography (OCT), fundus photography, and ultrasound have revolutionized the field, enabling healthcare professionals to detect retinal abnormalities with greater precision. This, in turn, fosters early intervention and improved patient outcomes.

Key Market Drivers

Increasing Prevalence of Retinal Disorders

The growing prevalence of retinal disorders is a major driver fueling the expansion of the global retinal detachment diagnostic market. As the incidence of vision-related diseases continues to rise worldwide, the demand for early detection, accurate diagnosis, and preventive screening has increased significantly. This trend is primarily driven by factors such as the rising diabetic population, aging demographics, increased cases of high myopia, and lifestyle-related ocular diseases. Diabetes is one of the most significant risk factors for retinal detachment, as it leads to diabetic retinopathy-a condition that damages retinal blood vessels and can progress to tractional retinal detachment (TRD) if left untreated. According to the IDF Diabetes Atlas (2021), 10.5% of the global adult population (aged 20-79 years) is affected by diabetes, with nearly 50% of cases going undiagnosed. This silent health crisis has significant implications for healthcare systems and diagnostic markets worldwide.

Projections indicate a 46% surge in diabetes cases by 2045, with 1 in 8 adults-approximately 783 million people-expected to be diabetic. This rapid escalation will drive higher demand for early screening technologies, retinal diagnostics, and preventive healthcare solutions, positioning the ophthalmic diagnostics sector for substantial growth in the coming decades. As diabetic patients are advised to undergo routine eye examinations, the demand for advanced retinal imaging diagnostics such as Optical Coherence Tomography (OCT), Fundus Photography, and Fluorescein Angiography has grown exponentially. Many governments and healthcare organizations have implemented diabetic eye screening initiatives to prevent vision loss, further driving demand for retinal diagnostic devices. As diabetes cases continue to surge, the retinal detachment diagnostic market is witnessing higher adoption of diagnostic technologies across hospitals, clinics, and telemedicine platforms.

The aging global population is a significant contributor to the rising prevalence of retinal detachment and related disorders. Older individuals are more prone to posterior vitreous detachment (PVD), a common precursor to retinal detachment. As life expectancy increases, age-related macular degeneration (AMD) is becoming a leading cause of vision impairment, requiring frequent retinal monitoring. In elderly individuals, the vitreous gel inside the eye shrinks, leading to retinal tears and detachment, increasing the demand for early diagnostic imaging. By 2050, an estimated 80% of the global elderly population will reside in low- and middle-income countries, signaling a demographic shift with profound economic and healthcare implications.

Key Market Challenges

Cost Constraints

One of the significant challenges facing the growth of the Global Retinal Detachment Diagnostic market is cost constraints. State-of-the-art diagnostic technologies, such as Optical Coherence Tomography (OCT) and high-resolution fundus cameras, are integral to accurate retinal detachment diagnosis. These advanced technologies often come with a substantial price tag. The cost of acquiring, maintaining, and upgrading such equipment can be prohibitive for smaller healthcare facilities and clinics, limiting their ability to provide comprehensive retinal diagnostics. In many regions, healthcare budgets are limited, and healthcare providers must allocate resources across various medical specialties. As a result, ophthalmology departments may struggle to secure funding for the purchase and maintenance of expensive retinal diagnostic equipment. This limitation can lead to inadequate access to retinal examinations in underserved areas. Reimbursement policies and rates for retinal diagnostic tests can vary significantly by country and region. In some cases, reimbursement may not cover the full cost of the diagnostic procedure, leaving healthcare providers with financial burdens. This can discourage facilities from investing in advanced retinal diagnostics and hinder market growth.

Key Market Trends

Telemedicine and Remote Monitoring

Advances in telemedicine technology have enabled ophthalmologists and retinal specialists to conduct virtual consultations with patients. Through video conferencing and digital imaging, healthcare providers can assess retinal health, monitor progression, and offer guidance remotely. This trend has become particularly important during the COVID-19 pandemic when in-person visits were limited. The emergence of wearable devices, such as smartphone-based fundus cameras and portable OCT devices, allows patients to capture retinal images at home. These images can be securely transmitted to healthcare providers for assessment. This trend not only enhances patient convenience but also facilitates early detection and continuous monitoring of retinal conditions. The data generated through telemedicine and remote monitoring can be analyzed using artificial intelligence (AI) algorithms. AI-powered software can assist in the early identification of retinal abnormalities and trends, improving diagnostic accuracy and enabling timely interventions. This data-driven approach is expected to play a pivotal role in the future of retinal diagnostics.

Key Market Players

• Canon Medical Systems Corporation
• Carl Zeiss Meditec Inc.
• Revenio Group Corporation (Centervue SpA)
• Eyenuk Inc.
• Essilor International SA
• HealPros LLC
• Millennium Surgical Corp.
• ONL Therapeutics
• Peek Vision Ltd
• Parata Systems (Synergy Medical) LLC

Report Scope:

In this report, the Global Retinal Detachment Diagnostic Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Retinal Detachment Diagnostic Market, By Disease Type:

• Rhegmatogenous Retinal Detachment
• Exudative
• Serous or Secondary Retinal Detachment
• Tractional Retinal Detachment

Retinal Detachment Diagnostic Market, By Diagnostics:

• Fundus Photography
• Ophthalmoscopy
• Digital Retinal Camera
• Fluorescent Retinal Angiography
• Others

Retinal Detachment Diagnostic Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Retinal Detachment Diagnostic Market.

Available Customizations:

Global Retinal Detachment Diagnostic market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Retinal Detachment Diagnostic Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Disease Type (Rhegmatogenous Retinal Detachment, Exudative, Serous or Secondary Retinal Detachment, Tractional Retinal Detachment)
  • 5.2.2. By Diagnostics (Fundus Photography, Ophthalmoscopy, Digital Retinal Camera, Fluorescent Retinal Angiography, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Retinal Detachment Diagnostic Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Disease Type
  • 6.2.2. By Diagnostics
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Retinal Detachment Diagnostic Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Disease Type
      • 6.3.1.2.2. By Diagnostics
  • 6.3.2. Canada Retinal Detachment Diagnostic Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Disease Type
      • 6.3.2.2.2. By Diagnostics
  • 6.3.3. Mexico Retinal Detachment Diagnostic Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Disease Type
      • 6.3.3.2.2. By Diagnostics

7. Europe Retinal Detachment Diagnostic Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Disease Type
  • 7.2.2. By Diagnostics
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Retinal Detachment Diagnostic Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Disease Type
      • 7.3.1.2.2. By Diagnostics
  • 7.3.2. United Kingdom Retinal Detachment Diagnostic Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Disease Type
      • 7.3.2.2.2. By Diagnostics
  • 7.3.3. Italy Retinal Detachment Diagnostic Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Disease Type
      • 7.3.3.2.2. By Diagnostics
  • 7.3.4. France Retinal Detachment Diagnostic Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Disease Type
      • 7.3.4.2.2. By Diagnostics
  • 7.3.5. Spain Retinal Detachment Diagnostic Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Disease Type
      • 7.3.5.2.2. By Diagnostics

8. Asia-Pacific Retinal Detachment Diagnostic Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Disease Type
  • 8.2.2. By Diagnostics
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Retinal Detachment Diagnostic Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Disease Type
      • 8.3.1.2.2. By Diagnostics
  • 8.3.2. India Retinal Detachment Diagnostic Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Disease Type
      • 8.3.2.2.2. By Diagnostics
  • 8.3.3. Japan Retinal Detachment Diagnostic Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Disease Type
      • 8.3.3.2.2. By Diagnostics
  • 8.3.4. South Korea Retinal Detachment Diagnostic Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Disease Type
      • 8.3.4.2.2. By Diagnostics
  • 8.3.5. Australia Retinal Detachment Diagnostic Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Disease Type
      • 8.3.5.2.2. By Diagnostics

9. South America Retinal Detachment Diagnostic Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Disease Type
  • 9.2.2. By Diagnostics
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Retinal Detachment Diagnostic Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Disease Type
      • 9.3.1.2.2. By Diagnostics
  • 9.3.2. Argentina Retinal Detachment Diagnostic Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Disease Type
      • 9.3.2.2.2. By Diagnostics
  • 9.3.3. Colombia Retinal Detachment Diagnostic Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Disease Type
      • 9.3.3.2.2. By Diagnostics

10. Middle East and Africa Retinal Detachment Diagnostic Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Disease Type
  • 10.2.2. By Diagnostics
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Retinal Detachment Diagnostic Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Disease Type
      • 10.3.1.2.2. By Diagnostics
  • 10.3.2. Saudi Arabia Retinal Detachment Diagnostic Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Disease Type
      • 10.3.2.2.2. By Diagnostics
  • 10.3.3. UAE Retinal Detachment Diagnostic Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Disease Type
      • 10.3.3.2.2. By Diagnostics

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Retinal Detachment Diagnostic Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Canon Medical Systems Corporation
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Carl Zeiss Meditec Inc.
• 14.3. Revenio Group Corporation (Centervue SpA)
• 14.4. Eyenuk Inc.
• 14.5. Essilor International SA
• 14.6. HealPros LLC
• 14.7. Millennium Surgical Corp.
• 14.8. ONL Therapeutics
• 14.9. Peek Vision Ltd
• 14.10.Parata Systems (Synergy Medical) LLC

15. Strategic Recommendations

16. About Us & Disclaimer